Chlorine in PDB 5xxi: Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules
Enzymatic activity of Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules
Protein crystallography data
The structure of Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules, PDB code: 5xxi
was solved by
K.Maekawa,
M.Adachi,
M.B.Shah,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.63 /
2.30
|
Space group
|
I 2 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
74.571,
142.958,
161.420,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.4 /
26.9
|
Other elements in 5xxi:
The structure of Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules
(pdb code 5xxi). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules, PDB code: 5xxi:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 5xxi
Go back to
Chlorine Binding Sites List in 5xxi
Chlorine binding site 1 out
of 4 in the Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl501
b:84.5
occ:1.00
|
CL
|
A:LSN501
|
0.0
|
84.5
|
1.0
|
C17
|
A:LSN501
|
1.8
|
78.3
|
1.0
|
N6
|
A:LSN501
|
2.9
|
73.7
|
1.0
|
C15
|
A:LSN501
|
2.9
|
67.3
|
1.0
|
C16
|
A:LSN501
|
3.4
|
79.7
|
1.0
|
CG2
|
A:VAL237
|
3.7
|
54.7
|
1.0
|
ND2
|
A:ASN204
|
3.7
|
54.3
|
1.0
|
CB
|
A:ALA106
|
3.9
|
84.4
|
1.0
|
CB
|
A:LEU233
|
4.0
|
51.9
|
1.0
|
N5
|
A:LSN501
|
4.0
|
69.5
|
1.0
|
C18
|
A:LSN501
|
4.0
|
71.7
|
1.0
|
O
|
A:ALA106
|
4.1
|
84.5
|
1.0
|
O
|
A:LSN501
|
4.1
|
96.0
|
1.0
|
CD1
|
A:LEU208
|
4.1
|
51.9
|
1.0
|
O
|
A:LEU233
|
4.4
|
64.8
|
1.0
|
CD2
|
A:LEU233
|
4.5
|
54.6
|
1.0
|
C
|
A:LEU233
|
4.5
|
58.3
|
1.0
|
CG
|
A:ASN204
|
4.5
|
62.2
|
1.0
|
CG
|
A:LEU233
|
4.6
|
62.0
|
1.0
|
CD2
|
A:LEU208
|
4.6
|
48.9
|
1.0
|
CD1
|
A:LEU233
|
4.6
|
57.5
|
1.0
|
CA
|
A:LEU233
|
4.7
|
63.4
|
1.0
|
CD
|
A:ARG108
|
4.8
|
77.5
|
1.0
|
CB
|
A:ASN204
|
4.8
|
59.4
|
1.0
|
CG
|
A:LEU208
|
4.8
|
53.2
|
1.0
|
CG
|
A:ARG108
|
4.8
|
81.0
|
1.0
|
CA
|
A:ALA106
|
4.9
|
84.5
|
1.0
|
C
|
A:ALA106
|
4.9
|
84.5
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 5xxi
Go back to
Chlorine Binding Sites List in 5xxi
Chlorine binding site 2 out
of 4 in the Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl502
b:0.7
occ:1.00
|
CL
|
A:LSN502
|
0.0
|
0.7
|
1.0
|
C17
|
A:LSN502
|
1.4
|
83.2
|
1.0
|
N6
|
A:LSN502
|
2.5
|
80.9
|
1.0
|
C15
|
A:LSN502
|
2.7
|
64.1
|
1.0
|
NZ
|
A:LYS232
|
2.9
|
78.6
|
1.0
|
CD
|
A:LYS232
|
3.0
|
61.2
|
1.0
|
CE
|
A:LYS232
|
3.1
|
63.7
|
1.0
|
C16
|
A:LSN502
|
3.4
|
69.9
|
1.0
|
NZ
|
A:LYS235
|
3.6
|
87.4
|
1.0
|
C18
|
A:LSN502
|
3.7
|
72.5
|
1.0
|
N5
|
A:LSN502
|
3.8
|
66.4
|
1.0
|
CG
|
A:LYS232
|
4.0
|
53.0
|
1.0
|
CD
|
A:LYS235
|
4.3
|
89.4
|
1.0
|
CB
|
A:LYS232
|
4.3
|
47.9
|
1.0
|
CE
|
A:LYS235
|
4.4
|
87.5
|
1.0
|
CA
|
A:LYS232
|
4.7
|
53.8
|
1.0
|
O
|
A:LSN502
|
4.7
|
70.0
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 5xxi
Go back to
Chlorine Binding Sites List in 5xxi
Chlorine binding site 3 out
of 4 in the Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl503
b:0.9
occ:0.70
|
CL
|
A:LSN503
|
0.0
|
0.9
|
0.7
|
C17
|
A:LSN503
|
1.4
|
0.2
|
0.7
|
N6
|
A:LSN503
|
1.5
|
81.7
|
0.3
|
O
|
A:GLN214
|
2.1
|
68.3
|
1.0
|
ND2
|
A:ASN218
|
2.3
|
73.4
|
1.0
|
C18
|
A:LSN503
|
2.6
|
75.0
|
0.3
|
C17
|
A:LSN503
|
2.6
|
82.6
|
0.3
|
N6
|
A:LSN503
|
2.6
|
0.1
|
0.7
|
C15
|
A:LSN503
|
2.7
|
0.1
|
0.7
|
CG
|
A:ASN218
|
3.1
|
75.2
|
1.0
|
C
|
A:GLN214
|
3.1
|
67.1
|
1.0
|
CB
|
A:ASN218
|
3.2
|
75.7
|
1.0
|
C19
|
A:LSN503
|
3.2
|
74.1
|
0.3
|
CL
|
A:LSN503
|
3.2
|
83.3
|
0.3
|
C16
|
A:LSN503
|
3.4
|
0.9
|
0.7
|
CA
|
A:ILE215
|
3.4
|
71.0
|
1.0
|
N
|
A:ILE215
|
3.7
|
69.3
|
1.0
|
N5
|
A:LSN503
|
3.7
|
80.9
|
0.3
|
C15
|
A:LSN503
|
3.8
|
81.7
|
0.3
|
N5
|
A:LSN503
|
3.8
|
0.8
|
0.7
|
C18
|
A:LSN503
|
3.8
|
0.6
|
0.7
|
O
|
A:ILE215
|
3.8
|
71.3
|
1.0
|
C
|
A:ILE215
|
4.1
|
71.5
|
1.0
|
OD1
|
A:ASN218
|
4.2
|
73.0
|
1.0
|
C20
|
A:LSN503
|
4.3
|
66.7
|
0.3
|
CZ
|
A:PHE69
|
4.4
|
93.2
|
1.0
|
CA
|
A:GLN214
|
4.4
|
65.4
|
1.0
|
O
|
A:LSN503
|
4.4
|
0.9
|
0.7
|
CG
|
A:PHE100
|
4.4
|
81.8
|
1.0
|
CD1
|
A:PHE100
|
4.5
|
84.9
|
1.0
|
CB
|
A:ILE215
|
4.6
|
71.5
|
1.0
|
CA
|
A:ASN218
|
4.6
|
76.4
|
1.0
|
CB
|
A:PHE100
|
4.6
|
78.7
|
1.0
|
CG1
|
A:ILE215
|
4.7
|
71.4
|
1.0
|
OE1
|
A:GLN214
|
4.8
|
71.8
|
1.0
|
CD2
|
A:PHE100
|
4.9
|
82.9
|
1.0
|
CE2
|
A:PHE69
|
4.9
|
92.9
|
1.0
|
CE1
|
A:PHE100
|
4.9
|
87.0
|
1.0
|
O
|
A:ILE213
|
4.9
|
58.1
|
1.0
|
N
|
A:ASN218
|
4.9
|
75.5
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 5xxi
Go back to
Chlorine Binding Sites List in 5xxi
Chlorine binding site 4 out
of 4 in the Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Crystal Structure of CYP2C9 in Complex with Multiple Losartan Molecules within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl503
b:83.3
occ:0.30
|
CL
|
A:LSN503
|
0.0
|
83.3
|
0.3
|
C17
|
A:LSN503
|
1.5
|
82.6
|
0.3
|
N6
|
A:LSN503
|
1.5
|
0.1
|
0.7
|
C17
|
A:LSN503
|
2.6
|
0.2
|
0.7
|
C18
|
A:LSN503
|
2.7
|
0.6
|
0.7
|
N6
|
A:LSN503
|
2.7
|
81.7
|
0.3
|
C15
|
A:LSN503
|
2.7
|
81.7
|
0.3
|
ND2
|
A:ASN218
|
2.7
|
73.4
|
1.0
|
CD2
|
A:LEU102
|
3.1
|
72.5
|
1.0
|
CL
|
A:LSN503
|
3.2
|
0.9
|
0.7
|
C19
|
A:LSN503
|
3.3
|
0.9
|
0.7
|
O
|
A:GLN214
|
3.4
|
68.3
|
1.0
|
C16
|
A:LSN503
|
3.4
|
75.4
|
0.3
|
CB
|
A:LEU102
|
3.4
|
77.3
|
1.0
|
O
|
A:LSN503
|
3.5
|
78.4
|
0.3
|
CG
|
A:LEU102
|
3.5
|
76.2
|
1.0
|
OE1
|
A:GLN214
|
3.6
|
71.8
|
1.0
|
CG
|
A:ASN218
|
3.7
|
75.2
|
1.0
|
N5
|
A:LSN503
|
3.8
|
0.8
|
0.7
|
C15
|
A:LSN503
|
3.8
|
0.1
|
0.7
|
C18
|
A:LSN503
|
3.8
|
75.0
|
0.3
|
N5
|
A:LSN503
|
3.9
|
80.9
|
0.3
|
C20
|
A:LSN503
|
3.9
|
0.7
|
0.7
|
C22
|
A:LSN503
|
4.0
|
67.6
|
0.7
|
CB
|
A:PHE100
|
4.0
|
78.7
|
1.0
|
OD1
|
A:ASN218
|
4.1
|
73.0
|
1.0
|
C21
|
A:LSN503
|
4.1
|
90.8
|
0.7
|
C
|
A:GLN214
|
4.3
|
67.1
|
1.0
|
CD
|
A:GLN214
|
4.4
|
74.0
|
1.0
|
CA
|
A:GLN214
|
4.5
|
65.4
|
1.0
|
CG
|
A:PHE100
|
4.5
|
81.8
|
1.0
|
CD2
|
A:PHE100
|
4.7
|
82.9
|
1.0
|
CA
|
A:LEU102
|
4.7
|
81.2
|
1.0
|
C13
|
A:LSN503
|
4.7
|
58.8
|
0.3
|
NE2
|
A:GLN214
|
4.7
|
76.6
|
1.0
|
O
|
A:ILE213
|
4.8
|
58.1
|
1.0
|
C10
|
A:LSN503
|
4.8
|
0.7
|
0.7
|
CB
|
A:ASN218
|
4.9
|
75.7
|
1.0
|
N
|
A:LEU102
|
4.9
|
74.7
|
1.0
|
|
Reference:
K.Maekawa,
M.Adachi,
Y.Matsuzawa,
Q.Zhang,
R.Kuroki,
Y.Saito,
M.B.Shah.
Structural Basis of Single-Nucleotide Polymorphisms in Cytochrome P450 2C9 Biochemistry V. 56 5476 2017.
ISSN: ISSN 1520-4995
PubMed: 28972767
DOI: 10.1021/ACS.BIOCHEM.7B00795
Page generated: Fri Jul 26 21:12:44 2024
|